» Articles » PMID: 28806330

NANOCI-Nanotechnology Based Cochlear Implant With Gapless Interface to Auditory Neurons

Abstract

: Cochlear implants (CI) restore functional hearing in the majority of deaf patients. Despite the tremendous success of these devices, some limitations remain. The bottleneck for optimal electrical stimulation with CI is caused by the anatomical gap between the electrode array and the auditory neurons in the inner ear. As a consequence, current devices are limited through 1) low frequency resolution, hence sub-optimal sound quality and 2), large stimulation currents, hence high energy consumption (responsible for significant battery costs and for impeding the development of fully implantable systems). A recently completed, multinational and interdisciplinary project called NANOCI aimed at overcoming current limitations by creating a gapless interface between auditory nerve fibers and the cochlear implant electrode array. This ambitious goal was achieved in vivo by neurotrophin-induced attraction of neurites through an intracochlear gel-nanomatrix onto a modified nanoCI electrode array located in the scala tympani of deafened guinea pigs. Functionally, the gapless interface led to lower stimulation thresholds and a larger dynamic range in vivo, and to reduced stimulation energy requirement (up to fivefold) in an in vitro model using auditory neurons cultured on multi-electrode arrays. In conclusion, the NANOCI project yielded proof of concept that a gapless interface between auditory neurons and cochlear implant electrode arrays is feasible. These findings may be of relevance for the development of future CI systems with better sound quality and performance and lower energy consumption. The present overview/review paper summarizes the NANOCI project history and highlights achievements of the individual work packages.

Citing Articles

Decreasing the physical gap in the neural-electrode interface and related concepts to improve cochlear implant performance.

Vecchi J, Claussen A, Hansen M Front Neurosci. 2024; 18:1425226.

PMID: 39114486 PMC: 11303154. DOI: 10.3389/fnins.2024.1425226.


The geometry of photopolymerized topography influences neurite pathfinding by directing growth cone morphology and migration.

Vecchi J, Rhomberg M, Guymon C, Hansen M J Neural Eng. 2024; 21(2).

PMID: 38547528 PMC: 10993768. DOI: 10.1088/1741-2552/ad38dc.


The current status of nanotechnological approaches to therapy and drug delivery in otolaryngology: A contemporary review.

Burruss C, Kacker A Laryngoscope Investig Otolaryngol. 2022; 7(6):1762-1772.

PMID: 36544970 PMC: 9764775. DOI: 10.1002/lio2.952.


Improving Control of Gene Therapy-Based Neurotrophin Delivery for Inner Ear Applications.

St Peter M, Brough D, Lawrence A, Nelson-Brantley J, Huang P, Harre J Front Bioeng Biotechnol. 2022; 10:892969.

PMID: 35721868 PMC: 9204055. DOI: 10.3389/fbioe.2022.892969.


Development of Neuronal Guidance Fibers for Stimulating Electrodes: Basic Construction and Delivery of a Growth Factor.

Wille I, Harre J, Oehmichen S, Lindemann M, Menzel H, Ehlert N Front Bioeng Biotechnol. 2022; 10:776890.

PMID: 35141211 PMC: 8819688. DOI: 10.3389/fbioe.2022.776890.


References
1.
Rask-Andersen H, Liu W . Auditory nerve preservation and regeneration in man: relevance for cochlear implantation. Neural Regen Res. 2015; 10(5):710-2. PMC: 4468758. DOI: 10.4103/1673-5374.156963. View

2.
Edin F, Liu W, Li H, Atturo F, Magnusson P, Rask-Andersen H . 3-D gel culture and time-lapse video microscopy of the human vestibular nerve. Acta Otolaryngol. 2014; 134(12):1211-8. DOI: 10.3109/00016489.2014.946536. View

3.
McGrath A, Novikova L, Novikov L, Wiberg M . BD™ PuraMatrix™ peptide hydrogel seeded with Schwann cells for peripheral nerve regeneration. Brain Res Bull. 2010; 83(5):207-13. DOI: 10.1016/j.brainresbull.2010.07.001. View

4.
Glueckert R, Bitsche M, Miller J, Zhu Y, Prieskorn D, Altschuler R . Deafferentation-associated changes in afferent and efferent processes in the guinea pig cochlea and afferent regeneration with chronic intrascalar brain-derived neurotrophic factor and acidic fibroblast growth factor. J Comp Neurol. 2008; 507(4):1602-21. DOI: 10.1002/cne.21619. View

5.
Wilson B, Dorman M . Cochlear implants: current designs and future possibilities. J Rehabil Res Dev. 2008; 45(5):695-730. DOI: 10.1682/jrrd.2007.10.0173. View